Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Transformative Research in Diabetic Nephropathy 2.0 — Stella

Home/Diabetic Nephropathies/Transformative Research in Diabetic Nephropathy 2.0

View on ClinicalTrials.gov

Recruiting

Back to Diabetic Nephropathies trials

Transformative Research in Diabetic Nephropathy 2.0

Trial locations(1 site)

United States

Penn Presbyterian Medical Center, Philadelphia, Pennsylvania

Key details

Sponsor

University of Pennsylvania

Collaborators

GlaxoSmithKline, Boehringer Ingelheim

Enrollment target

~200 participants

Started

November 2025

Primary completion

May 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.